BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30658716)

  • 1. Absence of herb-drug interactions of mistletoe with the tamoxifen metabolite (E/Z)-endoxifen and cytochrome P450 3A4/5 and 2D6 in vitro.
    Weissenstein U; Kunz M; Oufir M; Wang JT; Hamburger M; Urech K; Regueiro U; Baumgartner S
    BMC Complement Altern Med; 2019 Jan; 19(1):23. PubMed ID: 30658716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of a standardized mistletoe (Viscum album) preparation with antitumor effects of Trastuzumab in vitro.
    Weissenstein U; Kunz M; Urech K; Regueiro U; Baumgartner S
    BMC Complement Altern Med; 2016 Aug; 16():271. PubMed ID: 27491866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of standardized mistletoe (Viscum album) extracts with chemotherapeutic drugs regarding cytostatic and cytotoxic effects in vitro.
    Weissenstein U; Kunz M; Urech K; Baumgartner S
    BMC Complement Altern Med; 2014 Jan; 14():6. PubMed ID: 24397864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of extracts from mistletoe (Viscum album) for herb-drug interaction by inhibition and induction of cytochrome P450 activities.
    Doehmer J; Eisenbraun J
    Phytother Res; 2012 Jan; 26(1):11-7. PubMed ID: 21538623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine.
    Stearns V; Johnson MD; Rae JM; Morocho A; Novielli A; Bhargava P; Hayes DF; Desta Z; Flockhart DA
    J Natl Cancer Inst; 2003 Dec; 95(23):1758-64. PubMed ID: 14652237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological relevance of endoxifen in a laboratory simulation of breast cancer in postmenopausal patients.
    Maximov PY; McDaniel RE; Fernandes DJ; Bhatta P; Korostyshevskiy VR; Curpan RF; Jordan VC
    J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25258390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marsdenia tenacissima extract inhibits gefitinib metabolism in vitro by interfering with human hepatic CYP3A4 and CYP2D6 enzymes.
    Han SY; Zhao HY; Zhou N; Zhou F; Li PP
    J Ethnopharmacol; 2014; 151(1):210-7. PubMed ID: 24157377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploiting Pharmacokinetic Models of Tamoxifen and Endoxifen to Identify Factors Causing Subtherapeutic Concentrations in Breast Cancer Patients.
    Klopp-Schulze L; Joerger M; Wicha SG; Ter Heine R; Csajka C; Parra-Guillen ZP; Kloft C
    Clin Pharmacokinet; 2018 Feb; 57(2):229-242. PubMed ID: 28540639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic modelling to assess the impact of CYP2D6 and CYP3A metabolic phenotypes on the pharmacokinetics of tamoxifen and endoxifen.
    ter Heine R; Binkhorst L; de Graan AJ; de Bruijn P; Beijnen JH; Mathijssen RH; Huitema AD
    Br J Clin Pharmacol; 2014 Sep; 78(3):572-86. PubMed ID: 24697814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulation with cells in vitro of tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypes.
    Maximov PY; McDaniel RE; Fernandes DJ; Korostyshevskiy VR; Bhatta P; Mürdter TE; Flockhart DA; Jordan VC
    Br J Pharmacol; 2014 Dec; 171(24):5624-35. PubMed ID: 25073551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative potential from aqueous Viscum album L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells.
    Felenda JE; Turek C; Stintzing FC
    J Ethnopharmacol; 2019 May; 236():100-107. PubMed ID: 30840914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cells.
    Wu X; Hawse JR; Subramaniam M; Goetz MP; Ingle JN; Spelsberg TC
    Cancer Res; 2009 Mar; 69(5):1722-7. PubMed ID: 19244106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of novel tamoxifen analogues that avoid CYP2D6 metabolism.
    Ahmed NS; Elghazawy NH; ElHady AK; Engel M; Hartmann RW; Abadi AH
    Eur J Med Chem; 2016 Apr; 112():171-179. PubMed ID: 26896706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
    Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
    Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mistletoe (Viscum album) extract targets Axl to suppress cell proliferation and overcome cisplatin- and erlotinib-resistance in non-small cell lung cancer cells.
    Kim S; Kim KC; Lee C
    Phytomedicine; 2017 Dec; 36():183-193. PubMed ID: 29157814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapy.
    Teft WA; Gong IY; Dingle B; Potvin K; Younus J; Vandenberg TA; Brackstone M; Perera FE; Choi YH; Zou G; Legan RM; Tirona RG; Kim RB
    Breast Cancer Res Treat; 2013 May; 139(1):95-105. PubMed ID: 23580071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytochemical analysis and in vitro anti-proliferative activity of Viscum album ethanolic extracts.
    Holandino C; Melo MNO; Oliveira AP; Batista JVDC; Capella MAM; Garrett R; Grazi M; Ramm H; Torre CD; Schaller G; Urech K; Weissenstein U; Baumgartner S
    BMC Complement Med Ther; 2020 Jul; 20(1):215. PubMed ID: 32646417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice.
    Ruddy KJ; Desantis SD; Gelman RS; Wu AH; Punglia RS; Mayer EL; Tolaney SM; Winer EP; Partridge AH; Burstein HJ
    Breast Cancer Res Treat; 2013 Oct; 141(3):421-7. PubMed ID: 24062210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in the research of pharmacogenomics of tamoxifen].
    Xiong W; Zhao JJ; Wang L; Jiang XH; Tao XQ
    Yao Xue Xue Bao; 2016 Sep; 51(9):1356-67. PubMed ID: 29924509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ViscumTT induces apoptosis and alters IAP expression in osteosarcoma in vitro and has synergistic action when combined with different chemotherapeutic drugs.
    Kleinsimon S; Kauczor G; Jaeger S; Eggert A; Seifert G; Delebinski C
    BMC Complement Altern Med; 2017 Jan; 17(1):26. PubMed ID: 28061770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.